Thursday, October 02, 2014


They are clearly not prepared to deal with Ebola here.

DALLAS (AP) — The airline passenger who brought Ebola into the U.S. initially went to a
Dallas emergency room last week but was sent home, despite telling a nurse that he had been in
disease-ravaged West Africa, the hospital said Wednesday in a disclosure that showed how easily
an infection could be missed.

""The New York Times said that Duncan, in his mid-40s, helped transport a pregnant woman
suffering from Ebola to a hospital in Liberia, where she was turned away for lack of space.
Duncan helped bring the woman back to her family's home and carried her into the house, where
she later died, the newspaper reported.
Four days later Duncan left for the United States, the Times said, citing the woman's parents and
"His whole family was screaming. He got outside and he was throwing up all over the place,"
resident Mesud Osmanovic, 21, said on Wednesday, describing the chaotic scene before the man
was admitted to Texas Health Presbyterian Hospital on Sunday where he is in serious condition.


 How is it happening?  Perhaps he did not have Obamacare insurance.

Should we seal off the Texas borders after we fire the director of the secret service?


Anonymous Anonymous said...

Lock Down Party at the Bush Block!

10:11 AM  
Anonymous Anonymous said...

Chimerix itself reported:

Brincidofovir (CMX001) is an experimental antiviral drug being developed by Chimerix for the treatment of cytomegalovirus, adenovirus, Ebola virus disease, and smallpox. Brincidofovir is a prodrug of cidofovir.[1] Conjugated to a lipid, the compound is designed to release cidofovir intracellularly, allowing for higher intracellular and lower plasma concentrations of cidofovir, effectively increasing its activity against dsDNA viruses, as well as oral bioavailability.[2]

In animal trials the drug has shown activity against cytomegalovirus, adenoviruses, BK virus, smallpox, and herpes simplex viruses,[3][1] and preliminary tests have also shown it to have potential for the treatment of Ebola virus disease.[4]


Chimerix Inc.
2505 Meridian Parkway, Suite 340
Durham, NC 27713
Tel: (919) 806-1074
Fax: (919) 806-1146
Clinical Trials:
Investor Relations:
Human Resources:
Business Development:
Brincidofovir Expanded
Access Program:

Media and Investor Contact:

Joseph T. Schepers
Executive Director, Investor Relations
and Corporate Communications
(919) 287-4125

9:14 AM  
Anonymous Anonymous said...

Perhaps Obama has acquired a taste for "lock down parties" as well!

Another effoert to push Obamacare perhaps as well!

10:32 PM  

Post a Comment

<< Home